These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31485600)
1. Expression profile‑driven discovery of AURKA as a treatment target for liposarcoma. Yen CC; Chen SC; Hung GY; Wu PK; Chua WY; Lin YC; Yen CH; Chen YC; Wang JY; Yang MH; Chao Y; Chang MC; Chen WM Int J Oncol; 2019 Oct; 55(4):938-948. PubMed ID: 31485600 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma. Dickson MA; Mahoney MR; Tap WD; D'Angelo SP; Keohan ML; Van Tine BA; Agulnik M; Horvath LE; Nair JS; Schwartz GK Ann Oncol; 2016 Oct; 27(10):1855-60. PubMed ID: 27502708 [TBL] [Abstract][Full Text] [Related]
3. Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models. Kogiso M; Qi L; Braun FK; Injac SG; Zhang L; Du Y; Zhang H; Lin FY; Zhao S; Lindsay H; Su JM; Baxter PA; Adesina AM; Liao D; Qian MG; Berg S; Muscal JA; Li XN Clin Cancer Res; 2018 May; 24(9):2159-2170. PubMed ID: 29463553 [No Abstract] [Full Text] [Related]
4. Combination of Eribulin and Aurora A Inhibitor MLN8237 Prevents Metastatic Colonization and Induces Cytotoxic Autophagy in Breast Cancer. Kozyreva VK; Kiseleva AA; Ice RJ; Jones BC; Loskutov YV; Matalkah F; Smolkin MB; Marinak K; Livengood RH; Salkeni MA; Wen S; Hazard HW; Layne GP; Walsh CM; Cantrell PS; Kilby GW; Mahavadi S; Shah N; Pugacheva EN Mol Cancer Ther; 2016 Aug; 15(8):1809-22. PubMed ID: 27235164 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma. Park SI; Lin CP; Ren N; Angus SP; Dittmer DP; Foote M; Parton T; Bhatt AP; Fedoriw YD; Roth DP; Cann ML; Johnson GL; Damania B Target Oncol; 2019 Oct; 14(5):563-575. PubMed ID: 31429028 [TBL] [Abstract][Full Text] [Related]
6. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. Sehdev V; Peng D; Soutto M; Washington MK; Revetta F; Ecsedy J; Zaika A; Rau TT; Schneider-Stock R; Belkhiri A; El-Rifai W Mol Cancer Ther; 2012 Mar; 11(3):763-74. PubMed ID: 22302096 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines. Liu N; Wang YA; Sun Y; Ecsedy J; Sun J; Li X; Wang P Respir Res; 2019 Oct; 20(1):230. PubMed ID: 31647033 [TBL] [Abstract][Full Text] [Related]
8. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express Aurora kinase A. Yang J; Ikezoe T; Nishioka C; Nobumoto A; Udaka K; Yokoyama A Int J Cancer; 2013 Dec; 133(11):2706-19. PubMed ID: 23686525 [TBL] [Abstract][Full Text] [Related]
9. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Zhou N; Singh K; Mir MC; Parker Y; Lindner D; Dreicer R; Ecsedy JA; Zhang Z; Teh BT; Almasan A; Hansel DE Clin Cancer Res; 2013 Apr; 19(7):1717-28. PubMed ID: 23403633 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1. Wang-Bishop L; Chen Z; Gomaa A; Lockhart AC; Salaria S; Wang J; Lewis KB; Ecsedy J; Washington K; Beauchamp RD; El-Rifai W Gastroenterology; 2019 Feb; 156(3):662-675.e7. PubMed ID: 30342037 [TBL] [Abstract][Full Text] [Related]
11. Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma. Romain C; Paul P; Kim KW; Lee S; Qiao J; Chung DH J Pediatr Surg; 2014 Jan; 49(1):159-65. PubMed ID: 24439602 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells. Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923 [TBL] [Abstract][Full Text] [Related]
13. c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer. Li Y; Li X; Pu J; Yang Q; Guan H; Ji M; Shi B; Chen M; Hou P Thyroid; 2018 Dec; 28(12):1642-1654. PubMed ID: 30226440 [No Abstract] [Full Text] [Related]
14. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells. Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708 [TBL] [Abstract][Full Text] [Related]
15. AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer. Liu X; Li Z; Song Y; Wang R; Han L; Wang Q; Jiang K; Kang C; Zhang Q Oncotarget; 2016 May; 7(22):33152-64. PubMed ID: 27121204 [TBL] [Abstract][Full Text] [Related]
16. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Katsha A; Soutto M; Sehdev V; Peng D; Washington MK; Piazuelo MB; Tantawy MN; Manning HC; Lu P; Shyr Y; Ecsedy J; Belkhiri A; El-Rifai W Gastroenterology; 2013 Dec; 145(6):1312-22.e1-8. PubMed ID: 23993973 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib. Wang L; Arras J; Katsha A; Hamdan S; Belkhiri A; Ecsedy J; El-Rifai W Mol Oncol; 2017 Aug; 11(8):981-995. PubMed ID: 28417568 [TBL] [Abstract][Full Text] [Related]
18. Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma. Felgenhauer J; Tomino L; Selich-Anderson J; Bopp E; Shah N Neoplasia; 2018 Oct; 20(10):965-974. PubMed ID: 30153557 [TBL] [Abstract][Full Text] [Related]
19. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. Mohan P; Castellsague J; Jiang J; Allen K; Chen H; Nemirovsky O; Spyra M; Hu K; Kluwe L; Pujana MA; Villanueva A; Mautner VF; Keats JJ; Dunn SE; Lazaro C; Maxwell CA Oncotarget; 2013 Jan; 4(1):80-93. PubMed ID: 23328114 [TBL] [Abstract][Full Text] [Related]
20. Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer. Guo M; Lu S; Huang H; Wang Y; Yang MQ; Yang Y; Fan Z; Jiang B; Deng Y BMC Syst Biol; 2018 Dec; 12(Suppl 7):118. PubMed ID: 30547784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]